Drug Approval | March 07, 2024
Sakar's oncology unit receives EU GMP approval
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The plant will drive pharmaceutical innovation in the Northeastern India
Subscribe To Our Newsletter & Stay Updated
